Where does CureVac Real Estate GmbH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CureVac Real Estate GmbH ranks #28,515 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does CureVac Real Estate GmbH hold?

CureVac Real Estate GmbH holds 9 US utility patents granted between 2020 and 2022, spanning 9 technology areas.

What is CureVac Real Estate GmbH's Innovation Score?

CureVac Real Estate GmbH has an Innovation Score of 35.7 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is CureVac Real Estate GmbH's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for CureVac Real Estate GmbH.

What does claim depth mean for CureVac Real Estate GmbH's patents?

CureVac Real Estate GmbH's patents average 23.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the CureVac Real Estate GmbH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

CureVac Real Estate GmbH

Q: What technology areas does CureVac Real Estate GmbH focus on?

CureVac Real Estate GmbH's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 7 patents. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 9 granted patents across 9 technology areas, recorded in grant years 2020–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Curevac ranks #28,515 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 9 technology areas.

#28,515
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.7/100): 23.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R28515 · Foreign Corporation #28,515 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 9 grants
MID-PACK #28,515/49,997
PHOTO-FINISH C° Change Surgical
CPC-NARROW C12N · 9 areas
INNOV-THIN 35.7/100
CLAIMS-DENSE 23.0 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2022 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: C° Change Surgical LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
CureVac Real Estate · this assignee

36
3D Lighting… · lowest

7

What this shows Curevac's Innovation Score is 35.7/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Curevac's grants concentrate

CureVac Real Estate GmbH is a focused PatentsView assignee: 9 CPC subclasses with 77.8% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2020 (6 grants) versus a trough of 3 in 2022. By volume, Curevac sits between Critical Tattoo Supply, LLC and C° Change Surgical LLC.

Curevac's three-year grant acceleration

CureVac Real Estate GmbH shows 3 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Critical Tattoo S…

9
Crorama

9
Crystal Group

9
Cuesta Technology…

9
Cushy Holdings

9
Cyclacel

9
Cytonics

9
C° Change Surgical

9
Curevac Real Esta… ◀

9

What this shows CureVac holds 9 patents at rank #28,516, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CureVac

By rank, the assignees closest to #28,516 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in CureVac's primary technology class.

Curevac's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

CureVac Real Estate GmbH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	6	66.7%
2022	3	33.3%

Which technologies does CureVac Real Estate GmbH patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

B01D - Separation 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#28,515

of 49,997 tracked assignees

Innovation Score

35.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

CureVac Real Estate GmbH's patent record in context - here's where to go next.

CureVac Real Estate GmbH's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 77.8% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #28,515 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare CureVac Real Estate GmbH against Critical Tattoo Supply, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.